Synexus

Synexus, established in 1998, is a prominent provider of clinical trial services. The company specializes in offering comprehensive site and patient services designed to streamline the clinical research process. Their core offerings encompass trial planning, patient enrollment strategies, and ensuring global coverage for studies. Synexus leverages its expertise to facilitate efficient and effective clinical trials, supporting advancements in healthcare and biotechnology.

Operating with a workforce of 500-1,000 employees across 19 locations, Synexus demonstrates significant operational scale. The company's services are built around patient engagement and adaptable trial management models, aiming to accelerate research timelines. They provide turnkey solutions that integrate seamlessly with biotechnology and health service providers. For insights into the individuals driving these operations, one can explore Meet Synexus's team. This focus on operational excellence and a distributed presence allows Synexus to manage complex research projects effectively.

With a reported revenue of $58.2M, Synexus positions itself as a key player in the clinical trial services market. The company competes with entities such as Science 37 and Parexel, indicating a dynamic and competitive landscape. Synexus's funding history includes a $26 million investment in 2004, underscoring early-stage growth support. Interested parties can Explore financial highlights for a deeper dive into their economic performance and market standing. Their strategic approach to patient recruitment and global trial management supports a broad range of therapeutic areas.